Evidence receipt

Dren Bio: backed by Pfizer.

This receipt shows the source excerpts that support the displayed claim. An archive hash describes saved source bytes; it is separate from the record's proof history.

Sources

1. www.drenbio.com (opens source)

   Context from source

   The Series B financing was co-led by Aisling Capital and HBM Healthcare Investments, with participation by new marquee investors Pfizer, ArrowMark Partners and Revelation Partners.

   Retrieved

   2026-10-16

   Checked

   2026-10-16

   Archive fingerprint

   Saved source SHA-256: 92d0f5d5499379670ad4a7ba93346d676163a3cca8ba048541841e0c07137fa5